Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized follow-up of patients receiving intrathecal S(+)-ketamine
2006-000767-28Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketamine in Neuralgia and cancer pain, sponsored by Medical University of Vienna. Primary endpoint: Neurological and behavioral changes. Started Aug 2006; status: completed.
02
Drugs
ketamine
03
Conditions
Neuralgiacancer pain
Beyond the preview
Go deeper on 2006-000767-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000767-28.